Scale Biosciences
Scale Bio is transforming single cell research by providing innovative solutions that redefine accessibility, flexibility, and scalability.
Latest Scale Biosciences Content
Product News
Scale Bio Draws Nearly 1 Billion Cells in Global Health and Disease Research Challenge
Scale Biosciences (Scale Bio) announced today the winning projects of the 100 Million Cell Challenge representing more than a dozen projects addressing critical challenges in global health.
Product News
Quantum Leap in Single Cell Genomics: Scale Bio Launches Groundbreaking ‘100 Million Cell Challenge’ in Collaboration With Ultima Genomics and NVIDIA
Scale Biosciences (Scale Bio), announced the launch of the “100 Million Cell Challenge,” a global initiative aimed at pushing the boundaries of single-cell genomics research.
Industry Insight
How New Technology Can Leverage Single-Cell Omics Techniques
In this interview, we spoke to Jason Koth, product management lead at Scale Biosciences, to learn more about their new ScalePlex technology for leveraging and overcoming current limitations within single-cell genomics.
Product News
Scale Biosciences Announces ScalePlex Technology To Simplify Single Cell Genomics Studies of Any Scale
Novel multiplexing technology enables seamless sample pooling facilitating cost-efficient single cell experiments for compound screening and translational research.
Advertisement